CRYPTOCOCCUS-NEOFORMANS VERTEBRAL OSTEOMYELITIS

被引:0
作者
GUREVITZ, O
GOLDSCHMIEDREUVEN, A
BLOCK, C
KOPOLOVIC, J
FARFEL, Z
HASSIN, D
机构
[1] CHAIM SHEBA MED CTR, DEPT MED E, IL-52621 TEL HASHOMER, ISRAEL
[2] CHAIM SHEBA MED CTR, DEPT MICROBIOL, IL-52621 TEL HASHOMER, ISRAEL
[3] CHAIM SHEBA MED CTR, DEPT PATHOL, IL-52621 TEL HASHOMER, ISRAEL
来源
JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY | 1994年 / 32卷 / 04期
关键词
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A 67-year-old previously healthy woman presented with low back pain of 2 months duration and daily fever of 39-degrees-C for 3 weeks. CT scan showed a lytic lesion in the third lumbar vertebra and a small right lower lobe lung infiltrate with mediastinal lymphadenopathy. Culture of material obtained from open biopsy of the vertebra grew Cryptococcus neoformans var. neoformans, which was also demonstrated on histology. Cryptococcal antigen was detected in the patient's serum. Treatment with amphotericin B (1000 mg total dose) and oral 5-fluorocytosine, resulted in complete recovery and resolution of the chest X-rav findings with a follow-up of 2 years. Since this case, as well as most of the previously described cases of cryptococcal osteomyelitis, were in normal hosts, cryptococcal osteomyelitis should be considered in the differential diagnosis even in a normal host, and therefore, prior to possible invasive diagnostic procedures, cryptococcal antigen in the serum should be determined.
引用
收藏
页码:315 / 318
页数:4
相关论文
共 12 条
[1]  
BAKER RD, 1976, AM J CLIN PATHOL, V65, P83
[2]  
Barnett JA, 1983, YEASTS CHARACTERISTI
[3]  
BEHRMAN RE, 1990, REV INFECT DIS, V12, P181
[4]   PIGMENT PRODUCTION BY CRYPTOCOCCUS-NEOFORMANS FROM PARA-DIPHENOLS AND ORTHO-DIPHENOLS - EFFECT OF NITROGEN-SOURCE [J].
CHASKES, S ;
TYNDALL, RL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1975, 1 (06) :509-514
[5]   CRYPTOCOCCAL OSTEOMYELITIS - REPORT OF A CASE AND A REVIEW OF THE LITERATURE [J].
HAMMERSCHLAG, MR ;
DOMINGO, J ;
HALLER, JO ;
PAPAYANOPULOS, D .
CLINICAL PEDIATRICS, 1982, 21 (02) :109-112
[6]   THE EVOLUTION OF PULMONARY CRYPTOCOCCOSIS - CLINICAL IMPLICATIONS FROM A STUDY OF 41 PATIENTS WITH AND WITHOUT COMPROMISING HOST FACTORS [J].
KERKERING, TM ;
DUMA, RJ ;
SHADOMY, S .
ANNALS OF INTERNAL MEDICINE, 1981, 94 (05) :611-616
[7]  
KOSHI G, 1964, Indian J Pathol Bacteriol, V52, P264
[8]   IMPROVED DIAGNOSTIC MEDIUM FOR SEPARATION OF CRYPTOCOCCUS-NEOFORMANS VAR NEOFORMANS (SEROTYPE-A AND SEROTYPE-D) AND CRYPTOCOCCUS-NEOFORMANS VAR GATTII (SEROTYPE-B AND SEROTYPE-C) [J].
KWONCHUNG, KJ ;
POLACHECK, I ;
BENNETT, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 15 (03) :535-537
[9]  
MATSUSHITA T, 1985, CLIN ORTHOP RELAT R, P279
[10]  
MORRIS B, 1992, J MED VET MYCOL, V30, P309